Literature DB >> 11544905

Patterns of failure following CT-based 3-D irradiation for malignant glioma.

H Aydin1, I Sillenberg, H von Lieven.   

Abstract

BACKGROUND: This retrospective study was undertaken to analyze the patterns of failure in patients with malignant glioma after localized irradiation. PATIENTS AND MATERIALS: Recurrence patterns of 46 patients with malignant glioma (glioblastoma: 24, anaplastic astrocytoma: 15, anaplastic oligodendroglioma: 5, unclassified malignant glioma: 2) were studied using CT/MR scans and radiotherapy plan-plots. All patients were operated before and a total dose of 5,940 cGy was given after CT assisted and individually configurated 3-D planning using 7-15 slices at an in between distance of 5 mm. The target volume included a 2-3 cm margin beyond the tumor indicated by preoperative CT scan. The following parameters were analyzed: tumor size and type, size of perifocal edema and whether the edema was fully included into treatment volume and finally the location of the recurrent tumor. The maximal distance between primary tumor and recurrent tumor was measured and also the distance from the border of the primary tumor to the distant border of edema for a visual analysis.
RESULTS: Local limited volume irradiation was sufficient since 73.9% of recurrences occurred within 2 cm distance from primary tumor and 93.5% of recurrences occurred completely within 3 cm distance from primary tumor. Regarding the distance between primary tumor and recurrent tumor and the time interval until appearance of recurrent tumor it was not of importance if perifocal edema was included completely into treatment volume or not.
CONCLUSION: Limited volume irradiation of malignant glioma with a target volume 3 cm beyond that indicated by preoperative CT scan seems to be sufficient, since 93.5% of recurrences were completely within 3 cm distance from the margin of the tumor. Improvement of the results with larger treatment volumes are unlikely. Complete irradiation of perifocal edema was not found to be necessary.

Entities:  

Mesh:

Year:  2001        PMID: 11544905     DOI: 10.1007/pl00002424

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  24 in total

1.  Clinical target volume delineation in glioblastomas: pre-operative versus post-operative/pre-radiotherapy MRI.

Authors:  P Farace; M G Giri; G Meliadò; D Amelio; L Widesott; G K Ricciardi; S Dall'Oglio; A Rizzotti; A Sbarbati; A Beltramello; S Maluta; M Amichetti
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

2.  Evaluation of current clinical target volume definitions for glioblastoma using cell-based dosimetry stochastic methods.

Authors:  L Moghaddasi; E Bezak; W Harriss-Phillips
Journal:  Br J Radiol       Date:  2015-07-03       Impact factor: 3.039

3.  Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report.

Authors:  Mario Balducci; Giuseppina Apicella; Stefania Manfrida; Annunziato Mangiola; Alba Fiorentino; Luigi Azario; Giuseppe Roberto D'Agostino; Vincenzo Frascino; Nicola Dinapoli; Giovanna Mantini; Alessio Albanese; Pasquale de Bonis; Silvia Chiesa; Vincenzo Valentini; Carmelo Anile; Numa Cellini
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

4.  Clinical target volume definition for glioblastoma radiotherapy planning: magnetic resonance imaging and computed tomography.

Authors:  A Fiorentino; R Caivano; P Pedicini; V Fusco
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

5.  Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.

Authors:  Irwin H Lee; Morand Piert; Diana Gomez-Hassan; Larry Junck; Lisa Rogers; James Hayman; Randall K Ten Haken; Theodore S Lawrence; Yue Cao; Christina Tsien
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

6.  Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm.

Authors:  Eleftherios Archavlis; Nikolaos Tselis; Gerhard Birn; Peter Ulrich; Nikolaos Zamboglou
Journal:  J Neurooncol       Date:  2014-06-20       Impact factor: 4.130

7.  Hypofractionated reirradiation for recurrent malignant glioma.

Authors:  Guido Henke; Frank Paulsen; Joachim P Steinbach; Ute Ganswindt; Hana Isijanov; Rolf-Dieter Kortmann; Michael Bamberg; Claus Belka
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621

8.  Neuroimaging classification of progression patterns in glioblastoma: a systematic review.

Authors:  Rory J Piper; Keerthi K Senthil; Jiun-Lin Yan; Stephen J Price
Journal:  J Neurooncol       Date:  2018-03-30       Impact factor: 4.130

9.  Evaluation of high-grade astrocytoma recurrence patterns after radiotherapy in the era of temozolomide: A single institution experience.

Authors:  Arno Lotar Cordova; Taynná Vernalha Rocha Almeida; Cintia Mara da Silva; Pedro Argolo Piedade; Cristiane Maria Almeida; Carlos Genesio Bezzera Lima; Carolina Dutra; Rafael Martins Ferreira; Marcelo Neves Linhares; Valeriy Denyak
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-17

10.  Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging.

Authors:  Shulun Nie; Yufang Zhu; Jia Yang; Tao Xin; Song Xue; Xianbin Zhang; Jujie Sun; Dianbin Mu; Yongsheng Gao; Zhaoqiu Chen; Xingchen Ding; Jinming Yu; Man Hu
Journal:  Radiat Oncol       Date:  2021-06-07       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.